Pressure BioSciences, Inc., a life sciences company, engages in the research, development, and commercialization of pressure cycling technology (PCT) that uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. The company offers Barocycler instrumentation, which includes Barocycler NEP3229 that is capable of processing up to three samples simultaneously using its single-use PULSE Tubes; and Barocycler NEP2320, which processes one sample at a time and works on compressed air. It also provides consumable products comprising PULSE Tubes/FT500 that transmits the power of PCT from the Barocycler instrument to the sample; and ProteoSolve, a PCT-dependent method for the reproducible extraction of proteins from lipid-rich samples, including adipose and brain tissues, organelles, and membrane preparations. PCT has applications in a various life sciences areas, including sample preparation for genomic, proteomic, and small molecule studies; control of chemical (enzymatic) reactions; protein purification; pathogen inactivation; and immunodiagnostics. Its customers include researchers at academic laboratories, government agencies, and biotechnology, pharmaceutical, and other life sciences companies in the United States. The company was founded in 1978. It was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in 2004. Pressure BioSciences is based in South Easton, Massachusetts.